"My reaction was the same as 25 years ago, when I first saw the preclinical work on rapamycin-eluting stents — a technology from which millions of patients now benefit. I have the same intuition: introduce CD31 onto any human implant, and something similar will happen."
Pr Patrick W. Serruys
Established Professor of Interventional Medicine & Innovation, University of Galway